This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80381013
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel im Mai 2007 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en mayu de 2007 scientific article published on 24 May 2007 наукова стаття, опублікована в травні 2007
p:P577
wds:Q80381013-E6897A26-876E-4F1C-B0D6-0B1EAB11D871
wdt:P577
2007-05-24T00:00:00Z
p:P2093
wds:Q80381013-3A9FC639-C9F5-434B-9923-851DF91E1225 wds:Q80381013-72B42A3E-0F3E-4AEF-9D66-AC82217B4241 wds:Q80381013-7739FAAB-B743-4A48-9D35-479E3B388821 wds:Q80381013-F110CEEE-3CDA-4F32-A286-D8DA0F0074E0 wds:Q80381013-C00AAD1F-6573-42D2-842F-767A7DE9F3A5
wdt:P2093
Robert Coleman Nanette Mutrie Helen Crank Amanda J Daley John M Saxton
rdfs:label
Determinants of adherence to exercise in women treated for breast cancer Determinants of adherence to exercise in women treated for breast cancer
skos:prefLabel
Determinants of adherence to exercise in women treated for breast cancer Determinants of adherence to exercise in women treated for breast cancer
schema:name
Determinants of adherence to exercise in women treated for breast cancer Determinants of adherence to exercise in women treated for breast cancer
p:P1476
wds:Q80381013-E0496CEA-456A-432A-9C84-ADB9725DCB19
wdt:P1476
Determinants of adherence to exercise in women treated for breast cancer
p:P304
wds:Q80381013-3C1AC59E-4071-4707-BA6A-4FF70AB8E298
wdt:P304
392-399
p:P31
wds:Q80381013-98607D8C-815F-4E39-A181-2EC8D07C01F1
wdt:P31
wd:Q13442814
p:P921
wds:Q80381013-CDE000BF-5FB3-40B6-9ADE-8CE28704A29E
wdt:P921
wd:Q128581
p:P698
wds:Q80381013-7E6AEBE8-3DDA-4965-B925-A0AB53F8C3E8
wdtn:P698
n12:17524796
wdt:P698
17524796
p:P1433
wds:Q80381013-9370A6A2-F25D-478A-8D5F-EB9B2C6F2EA6
wdt:P1433
wd:Q15756950
p:P433
wds:Q80381013-AEC6A9BF-7A5C-46A5-9BC8-C0D7CDB9C18E
p:P478
wds:Q80381013-88042A00-3225-4E98-A1B5-B64E566B8927
wdt:P433
5
wdt:P478
11
p:P356
wds:Q80381013-638A6281-20EF-4ED3-990C-4643FD003E82
wdtn:P356
n10:J.EJON.2007.03.001
wdt:P356
10.1016/J.EJON.2007.03.001